| Fd&c Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | SOLUTION / ORAL | | 38 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SOLUTION / ORAL | | 70200 mg | Exact identifier — unii candidate 36 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | | 2 mg | Exact identifier — unii candidate 36 equally ranked IID candidates |
| D&c Red No. 28 | D&C RED NO. 28 | 767IP0Y5NH | SUSPENSION / ORAL | 2.5 mg/5ml | | Exact identifier — unii candidate 11 equally ranked IID candidates |
| D&c Red No. 28 | D&C RED NO. 28 | 767IP0Y5NH | CAPSULE, EXTENDED RELEASE / ORAL | 0.2 mg | | Exact identifier — unii candidate 11 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SWAB / TOPICAL | | 5250 mg | Exact identifier — unii candidate 36 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | INJECTION, SUSPENSION / INTRAMUSCULAR | | 87 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | SUPPOSITORY / RECTAL | | 5704 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | INJECTION / INTRAMUSCULAR | | 56 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | TABLET, EXTENDED RELEASE / ORAL | | 60 mg | Exact identifier — unii candidate 36 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | TABLET, CHEWABLE / ORAL | 15 mg | | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Fd&c Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | DROPS / ORAL | NA | | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Fd&c Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, EXTENDED RELEASE / ORAL | | 1 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | FILM / ORAL | | 1 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | AEROSOL, POWDER / TOPICAL | NA | | Exact identifier — unii candidate 36 equally ranked IID candidates |
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | TROCHE / ORAL | | 60 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | INJECTION / INTRAVENOUS | 0.5 ml | | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | SUSPENSION / SUBCUTANEOUS | 2.88 %w/v | | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | INJECTION, SUSPENSION / INTRA-ARTICULAR | | 56 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | FILM, SOLUBLE / ORAL | | 29 mg | Exact identifier — unii candidate 36 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | INJECTION, SUSPENSION / SOFT TISSUE | | 87 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | CAPSULE / ORAL | | 576 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | GEL / TOPICAL | | 6300 mg | Exact identifier — unii candidate 36 equally ranked IID candidates |
| D&c Red No. 28 | D&C RED NO. 28 | 767IP0Y5NH | CAPSULE, COATED PELLETS / ORAL | NA | | Exact identifier — unii candidate 11 equally ranked IID candidates |
| Fd&c Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, DELAYED RELEASE / ORAL | | 2 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | GRANULE, FOR SUSPENSION / ORAL | | 23 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | LIQUID / TOPICAL | 1 %w/w | | Exact identifier — unii candidate 36 equally ranked IID candidates |
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | POWDER, FOR SUSPENSION / ORAL | | 400 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | TABLET, ORALLY DISINTEGRATING / ORAL | | 60 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | TABLET / ORAL | | 52 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Fd&c Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 0.02 mg | | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SOLUTION / TOPICAL | | 11100 mg | Exact identifier — unii candidate 36 equally ranked IID candidates |
| Fd&c Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET / SUBLINGUAL | NA | | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SUSPENSION / ORAL | | 400 mg | Exact identifier — unii candidate 36 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | INJECTION / INTRA-ARTICULAR | | 56 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | GRANULE / ORAL | 5.4 mg | | Exact identifier — unii candidate 22 equally ranked IID candidates |
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | GUM, CHEWING / BUCCAL | | 70 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | OINTMENT / TOPICAL | | 1179 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Fd&c Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | SPONGE / TOPICAL | NA | | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | CAPSULE / ORAL | | 13440 mg | Exact identifier — unii candidate 36 equally ranked IID candidates |
| Fd&c Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | SYRUP / ORAL | | 3 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | FILM, SOLUBLE / ORAL | | 33 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| Fd&c Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | CONCENTRATE / ORAL | 0.04 mg/1ml | | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Fd&c Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, FILM COATED / ORAL | 2.5 mg | | Exact identifier — unii candidate 28 equally ranked IID candidates |
| D&c Red No. 28 | D&C RED NO. 28 | 767IP0Y5NH | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | | Exact identifier — unii candidate 11 equally ranked IID candidates |
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | LOZENGE / ORAL | | 115 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| D&c Red No. 28 | D&C RED NO. 28 | 767IP0Y5NH | POWDER, FOR SUSPENSION / ORAL | 0.7 mg/5ml | | Exact identifier — unii candidate 11 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SOLUTION, CONCENTRATE / ORAL | | 2813 mg | Exact identifier — unii candidate 36 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | SUPPOSITORY / VAGINAL | NA | | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | CAPSULE, LIQUID FILLED / ORAL | | 1122 mg | Exact identifier — unii candidate 36 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | INJECTION, SUSPENSION / SUBCUTANEOUS | 2.88 %w/v | | Exact identifier — unii candidate 28 equally ranked IID candidates |
| D&c Red No. 28 | D&C RED NO. 28 | 767IP0Y5NH | CAPSULE, DELAYED RELEASE / ORAL | | 1 mg | Exact identifier — unii candidate 11 equally ranked IID candidates |
| Fd&c Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET / BUCCAL | 0.01 mg | | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | TABLET, DELAYED RELEASE / ORAL | | 35 mg | Exact identifier — unii candidate 36 equally ranked IID candidates |
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | SYRUP / ORAL | | 80 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | TABLET / ORAL | | 45 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | TABLET, DELAYED RELEASE / ORAL | | 10 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Fd&c Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | SHAMPOO / TOPICAL | | 2 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| Polyethylene Glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SPRAY, METERED / NASAL | | 320 mg | Exact identifier — unii candidate 36 equally ranked IID candidates |
| Fd&c Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, CHEWABLE / ORAL | 40 mg | | Exact identifier — unii candidate 28 equally ranked IID candidates |